Detalhe da pesquisa
1.
Dendritic cells can prime anti-tumor CD8+ T cell responses through major histocompatibility complex cross-dressing.
Immunity
; 55(6): 982-997.e8, 2022 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35617964
2.
Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma.
Blood
; 2024 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38484137
3.
Dendritic cells can prime anti-tumor CD8+ T cell responses through major histocompatibility complex cross-dressing.
Immunity
; 55(11): 2206-2208, 2022 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36351377
4.
Pembrolizumab plus vorinostat induces responses in patients with Hodgkin lymphoma refractory to prior PD-1 blockade.
Blood
; 142(16): 1359-1370, 2023 Oct 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37339586
5.
Results from a phase I trial of pembrolizumab plus vorinostat in relapsed/refractory B-cell non-Hodgkin lymphoma.
Haematologica
; 109(2): 533-542, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37470137
6.
Low T-cell proportion in the tumor microenvironment is associated with immune escape and poor survival in diffuse large B-cell lymphoma.
Haematologica
; 108(8): 2167-2177, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36632739
7.
Bendamustine lymphodepletion is a well-tolerated alternative to fludarabine and cyclophosphamide lymphodepletion for axicabtagene ciloleucel therapy for aggressive B-cell lymphoma.
Am J Hematol
; 98(11): 1751-1761, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37668287
8.
The immune landscape and response to immune checkpoint blockade therapy in lymphoma.
Blood
; 135(8): 523-533, 2020 02 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31790142
9.
PD-L1 gene alterations identify a subset of diffuse large B-cell lymphoma harboring a T-cell-inflamed phenotype.
Blood
; 133(21): 2279-2290, 2019 05 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-30910787
10.
Checkpoint blockade treatment sensitises relapsed/refractory non-Hodgkin lymphoma to subsequent therapy.
Br J Haematol
; 191(1): 44-51, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32430944
11.
Checkpoint Blockade Treatment May Sensitize Hodgkin Lymphoma to Subsequent Therapy.
Oncologist
; 25(10): 878-885, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32720734
12.
Impact of Treatment Beyond Progression with Immune Checkpoint Blockade in Hodgkin Lymphoma.
Oncologist
; 25(6): e993-e997, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32275786
13.
Diagnostic utility of STAT6YE361 expression in classical Hodgkin lymphoma and related entities.
Mod Pathol
; 33(5): 834-845, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31822802
14.
Mechanisms of Immune Tolerance in Leukemia and Lymphoma.
Trends Immunol
; 38(7): 513-525, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28511816
15.
Phase 1 study of lenalidomide plus dose-adjusted EPOCH-R in patients with aggressive B-cell lymphomas with deregulated MYC and BCL2.
Cancer
; 125(11): 1830-1836, 2019 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30707764
16.
Real-world experience of axicabtagene ciloleucel, a CD19-directed CAR T-cell therapy, in the second-line treatment of early relapsed or primary refractory large B-cell lymphoma.
Br J Haematol
; 2024 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38797530
17.
Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure.
Cancer
; 124(12): 2541-2551, 2018 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29645093
18.
Primary resistance to CD19-directed chimeric antigen receptor T-cell therapy in T-cell/histiocyte-rich large B-cell lymphoma.
Blood
; 137(24): 3454-3459, 2021 06 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33881502
19.
Outcomes of adults and children with primary mediastinal B-cell lymphoma treated with dose-adjusted EPOCH-R.
Br J Haematol
; 179(5): 739-747, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29082519
20.
That's why I take my ONS. Means-end chain as a novel approach to elucidate the personally relevant factors driving ONS consumption in nutritionally frail elderly users.
Appetite
; 89: 33-40, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25624023